Sage Therapeutics to Present at the 42nd Annual J.P. Morgan Healthcare Conference on Monday, January 8, 2024
January 02 2024 - 6:30AM
Business Wire
Sage Therapeutics, Inc. (NASDAQ: SAGE), a biopharmaceutical
company leading the way to create a world with better brain health,
announced today that the Company will present at the 42nd Annual
J.P. Morgan Healthcare Conference on Monday, January 8, 2024 at
4:30 p.m. PT in San Francisco, CA.
A live webcast of the presentation can be accessed on the
Investor page of Sage’s website at investor.sagerx.com. A replay of
the webcast will be available following the completion of the event
and will be archived for up to 30 days.
About Sage Therapeutics
Sage Therapeutics is a biopharmaceutical company fearlessly
leading the way to create a world with better brain health. Our
mission is to pioneer solutions to deliver life-changing brain
health medicines, so every person can thrive. For more information,
please visit www.sagerx.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240102349279/en/
Investor Ashley Kaplowitz 786-252-1419
ashley.kaplowitz@sagerx.com Media Contact Matthew Henson
917-930-7147 matthew.henson@sagerx.com
Sage Therapeutics (NASDAQ:SAGE)
Historical Stock Chart
From Apr 2024 to May 2024
Sage Therapeutics (NASDAQ:SAGE)
Historical Stock Chart
From May 2023 to May 2024